Cargando…
Triple therapy in COPD: understanding the data
Effectiveness of single-inhaler triple therapy on exacerbation risk and mortality in COPD is exaggerated in IMPACT and ETHOS trials from confounding by prior ICS discontinuation: effectiveness fades in analyses and studies with no prior ICS discontinuation https://bit.ly/3tOgNdW
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885273/ https://www.ncbi.nlm.nih.gov/pubmed/36726367 http://dx.doi.org/10.1183/23120541.00615-2022 |
_version_ | 1784879900607381504 |
---|---|
author | Suissa, Samy |
author_facet | Suissa, Samy |
author_sort | Suissa, Samy |
collection | PubMed |
description | Effectiveness of single-inhaler triple therapy on exacerbation risk and mortality in COPD is exaggerated in IMPACT and ETHOS trials from confounding by prior ICS discontinuation: effectiveness fades in analyses and studies with no prior ICS discontinuation https://bit.ly/3tOgNdW |
format | Online Article Text |
id | pubmed-9885273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-98852732023-01-31 Triple therapy in COPD: understanding the data Suissa, Samy ERJ Open Res Editorials Effectiveness of single-inhaler triple therapy on exacerbation risk and mortality in COPD is exaggerated in IMPACT and ETHOS trials from confounding by prior ICS discontinuation: effectiveness fades in analyses and studies with no prior ICS discontinuation https://bit.ly/3tOgNdW European Respiratory Society 2023-01-30 /pmc/articles/PMC9885273/ /pubmed/36726367 http://dx.doi.org/10.1183/23120541.00615-2022 Text en Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Editorials Suissa, Samy Triple therapy in COPD: understanding the data |
title | Triple therapy in COPD: understanding the data |
title_full | Triple therapy in COPD: understanding the data |
title_fullStr | Triple therapy in COPD: understanding the data |
title_full_unstemmed | Triple therapy in COPD: understanding the data |
title_short | Triple therapy in COPD: understanding the data |
title_sort | triple therapy in copd: understanding the data |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885273/ https://www.ncbi.nlm.nih.gov/pubmed/36726367 http://dx.doi.org/10.1183/23120541.00615-2022 |
work_keys_str_mv | AT suissasamy tripletherapyincopdunderstandingthedata |